47 completed, 15 unknown, 6 terminated, 4 withdrawn. 73 Phase 2, 15 Phase 3, 13 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 73 | Completed 47, Unknown 15, Terminated 6, Withdrawn 4, Active not recruiting 1 |
| Phase 3 | 15 | Completed 9, Unknown 4, Terminated 2 |
| Phase 1 | 13 | Completed 8, Unknown 4, Terminated 1 |
Follow Acute Myocardial Infarction: new trials by email Literature Review of Acute Myocardial Infarction trials Research Report on Acute Myocardial Infarction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction NL005 Middle Dose, NL005 High Dose, Placebo - Acute Myocardial Infarction | Phase 2 | Completed | Beijing Northland Biotech. Co., Ltd. | 90 | 2022-07-15 | 2024-06-21 |
| Low-Dose Dobutamine and Single-Dose Tocilizumab in Acute Myocardial Infarction With High Risk of Cardiogenic Shock Tocilizumab, Dobutamine, NaCl 0.9% - Acute Myocardial Infarction, Cardiogenic Shock | Phase 2 | Active not recruiting | Copenhagen University Hospital, Rigshospitalet | 100 | 2022-03-13 | 2025-07-17 |
| Ticagrelor Monotherapy After Stenting Ticagrelor 90mg - Acute Myocardial Infarction | Phase 2 | Completed | Vastra Gotaland Region | 200 | 2021-12-14 | 2026-03-20 |
| Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.Infarction Low Dose, Middle Dose, High Dose - Acute Myocardial Infarction | Phase 2 | Completed | Beijing Northland Biotech. Co., Ltd. | 62 | 2020-11-23 | 2022-08-03 |
| WJMSCs Anti-inflammatory Therapy in Acute Myocardial Infarction Intravenous infusion placebo, Intravenous infusion WJMSCs - Acute Myocardial Infarction | Phase 2 | Unknown | Navy General Hospital, Beijing | 200 | 2020-11-01 | 2020-09-16 |
| Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack BAY2433334, BAY2433334 matching placebo - Acute Myocardial Infarction | Phase 2 | Completed | Bayer | 1601 | 2020-06-17 | 2023-04-05 |
| A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction Drug: Placebo, Drug: Injectable Thymosin beta 4 - Acute Myocardial Infarction, ST Elevation Myocardial Infarction | Phase 2 | Withdrawn | RegeneRx Biopharmaceuticals, Inc. | 2019-07-01 | 2021-09-22 | |
| Stem Cell in Acute Myocardial Infarction Mesenchymal Stem Cells - Acute Myocardial Infarction | Phase 1 / Phase 2 | Completed | PT. Prodia Stem Cell Indonesia | 4 | 2019-03-11 | 2022-06-14 |
| Study of Dutogliptin in Combination With Filgrastim in Post-Myocardial Infarction Dutogliptin Tartrate, Filgrastim Injectable Product, Placebos - Acute Myocardial Infarction, Acute Myocardial Ischemia | Phase 2 | Completed | Recardio, Inc. | 49 | 2018-12-07 | 2021-05-27 |
| A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Heart Attack Selatogrel 8 mg, Selatogrel 16 mg - Acute Myocardial Infarction | Phase 2 | Completed | Viatris Innovation GmbH | 48 | 2018-07-10 | 2026-07-29 |
| 68 Ga-NODAGA-E[c(RGDγK)]2: Positron Emission Tomography Tracer for Imaging of Myocardial Angiogenesis 68Ga-NODAGA-E[c(RGDyK)]2 - Acute Myocardial Infarction | Phase 2 | Completed | Copenhagen University Hospital, Rigshospitalet | 42 | 2018-02-20 | 2020-07-14 |
| Safety and Efficacy Study of Gene Therapy for Acute Myocardial Infarction in Korea Stage 1-Low dose VM202RY, Stage 1-Middle dose VM202RY, Stage 1-High dose VM202RY - Ischemic Heart Disease, Acute Myocardial Infarction | Phase 2 | Withdrawn | Helixmith Co., Ltd. | 2018-01-25 | 2025-09-25 | |
| A Study of Acute Myocardial Infarction Using FDY-5301 FDY-5301, Placebo - Acute Myocardial Infarction, STEMI | Phase 2 | Completed | Faraday Pharmaceuticals, Inc. | 120 | 2017-10-27 | 2026-01-16 |
| Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate in STEMI Patients Lysine Acetilsalicilate, Aspirin - Acute Myocardial Infarction | Phase 2 / Phase 3 | Unknown | Fundacion Investigacion Interhospitalaria Cardiovascular | 60 | 2016-10-01 | 2016-10-11 |
| A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction CSL_112, Placebo - Acute Myocardial Infarction, Moderate Renal Impairment | Phase 2 | Completed | CSL Behring | 83 | 2016-08-01 | 2020-06-11 |
| Safety and Exploratory Efficacy Study of UCMSCs in Patients With Ischemic Heart Disease (SEESUPIHD) umbilical cord mesenchymal stem cells - Acute Myocardial Infarction, Myocardial Infarction | Phase 1 / Phase 2 | Unknown | South China Research Center for Stem Cell and Regenerative Medicine | 64 | 2016-05-01 | 2016-01-28 |
| EXCELLENT (EXpanded CELL ENdocardiac Transplantation) PROTHERACYTES, Standard Treatment for CHF post AMI - Acute Myocardial Infarction | Phase 2 | Completed | CellProthera | 49 | 2016-02-10 | 2026-03-19 |
| Therapy of Preconditioned Autologous BMMSCs for Patients With Ischemic Heart Disease BMMSCs - Myocardial Infarction, Acute Myocardial Infarction | Phase 1 / Phase 2 | Unknown | Academy Military Medical Science, China | 200 | 2015-11-01 | 2015-07-22 |
| Cyclosporine in Acute Myocardial Infarction Complicated by Cardiogenic Shock Single bolus of Placebo of CicloMulsion® (Neurovive)., Single bolus of cyclosporine A (CicloMulsion®, Neurovive) - Acute Myocardial Infarction | Phase 2 | Withdrawn | Hospices Civils de Lyon | 2015-09-01 | 2016-03-16 | |
| Interest of COLchicine in the Treatment of Patients With Acute Myocardial INfarction and With Inflammatory Response Colchimax®, Conventional treatment - Acute Myocardial Infarction | Phase 2 | Completed | University Hospital, Montpellier | 44 | 2014-12-01 | 2017-01-18 |
Showing 20 of 73. Sign in to see all of them.
ST Elevation Myocardial Infarction (11) · Myocardial Infarction (8) · Heart Failure (6) · Coronary Artery Disease (3) · Inflammation (3) · Shock, Cardiogenic (3) · Cardiovascular Diseases (2) · Myocardial Ischemia (2) · Non-ST Elevated Myocardial Infarction (2) · Reperfusion Injury (2) · Vascular Diseases (2) · Ventricular Remodeling (2) · Acute Coronary Syndrome (1) · Atherosclerosis (1) · Blushing (1)
Cardiovascular Diseases (32) · Heart Diseases (30) · Pathological Conditions, Signs and Symptoms (28) · Vascular Diseases (28) · Pathologic Processes (27) · Ischemia (23) · Myocardial Ischemia (23) · Necrosis (23) · Infarction (22) · Myocardial Infarction (14) · Arterial Occlusive Diseases (3) · Arteriosclerosis (3) · Coronary Disease (3) · Pathological Conditions, Anatomical (3) · Shock (3)
Sodium Chloride (6) · Filgrastim (3) · Abciximab (2) · Control Groups (2) · Drug-Eluting Stents (2) · Interleukin 1 Receptor Antagonist Protein (2) · Melatonin (2) · Nitric Oxide (2) · Acetylcysteine (1) · Aspirin (1) · CSL112 (1) · Cell- and Tissue-Based Therapy (1) · Contraceptives, Oral (1) · Dobutamine (1) · Doxycycline (1)
Copenhagen University Hospital, Rigshospitalet (3) · Virginia Commonwealth University (3) · Beijing Northland Biotech. Co., Ltd. (2) · CSL Behring (2) · Russian Academy of Medical Sciences (2) · Aarhus University Hospital Skejby (1) · Abbott RDx Cardiometabolic (1) · Academy Military Medical Science, China (1) · Alberto Domínguez Rodríguez (1) · Archemix Corp. (1) · Assaf-Harofeh Medical Center (1) · Azienda Unita Sanitaria Locale di Piacenza (1) · Bayer (1) · C. Michael Gibson, MS, MD (1) · CellProthera (1)
United States (17) · Germany (9) · Denmark (8) · Netherlands (8) · Hungary (7) · Italy (7) · France (6) · Poland (6) · Belgium (5) · Israel (5) · Spain (5) · United Kingdom (5) · South Korea (4) · Switzerland (4) · Austria (3)
Antonio Abbate, MD, PhD (2) · KeFei Dou (2) · Alan Maisel, MD (1) · Alberto Dominguez-Rodriguez, MD, PhD, FESC (1) · Andreas M Zeiher, MD (1) · Angel Leon, MD (1) · Antonio Abbate, M.D., Ph.D. (1) · Antonio L Bartorelli, MD (1) · Ashok Seth, FRCP, FACC (1) · Benjamin Van Tassell, PharmD (1) · Bert Andersson, Prof MD (1) · C. Michael Gibson, MS, MD (1) · Christopher B Granger, MD (1)
PMID 33217027, PMID 39531530, PMID 16807414, PMID 17123867, PMID 17161051, PMID 18535785, PMID 18598362, PMID 18845667, PMID 19131132, PMID 19539255, PMID 19781402, PMID 19910293, PMID 20102300, PMID 20576835, PMID 20598973, PMID 20961630, PMID 21127322, PMID 21132310, PMID 21299845, PMID 21372740, PMID 22236126, PMID 22449332, PMID 22503057, PMID 23281844, PMID 23453459, PMID 23596006, PMID 24431901, PMID 24467979, PMID 24495883, PMID 24925330, PMID 25121719, PMID 25482680, PMID 26098589, PMID 26296299, PMID 26321236, PMID 26709136, PMID 27267068, PMID 27659879, PMID 27881559, PMID 28533209, PMID 29634656, PMID 29800130, PMID 29921651, PMID 30033595, PMID 30580130, PMID 30602360, PMID 30957581, PMID 31151405, PMID 31870492, PMID 31982162
2005 (1), 2015 (1), 2018 (1), 2019 (1), R01HL103927 (1), R34HL121402 (1)